Trinity Bivalacqua, MD, PhD, addresses updates in high-risk BCG-unresponsive NMIBC treatment presented at ASCO 2024.
UroView
Advertisement
Advertisement
Trending on Urology Times
1
What income and estate tax provisions are in the One Big Beautiful Bill Act?
2
FDA approves fosfomycin for complicated urinary tract infections
3
Phase 2 trial of IL-15 superagonist launches in NMIBC
4
Trial launches of Optilume drug-coated balloon for benign ureteric strictures
5
